Potencies of Newer Fluoroquinolones against Viridans Group Streptococci Isolated in 637 Cases of Bloodstream Infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada!

Ähnliche Einträge

• Macrolide and Fluoroquinolone (Levofloxacin) Resistances among Streptococcus pneumoniae Strains: Significant Trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997–1999)
  von: Jones, Ronald N., et al.
  Veröffentlicht: (2000)
• Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
  von: Pfaller, Michael A., et al.
  Veröffentlicht: (1998)
• In Vitro Activities of Fluoroquinolones against Antibiotic-Resistant Blood Culture Isolates of Viridans Group Streptococci from across Canada
  von: de Azavedo, J. C. S., et al.
  Veröffentlicht: (1999)
• International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program
  von: Pfaller, M. A., et al.
  Veröffentlicht: (1998)
• Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
  von: Pfaller, M. A., et al.
  Veröffentlicht: (2000)